https://www.selleckchem.com/pr....oducts/cct128930.htm
001), and predominantly occurred in piv-mecillinam treated children 5years 7/20 (35%) versus 9/54 (17%) (p0.05), potentially because of problems with piv-mecillinam tablets. In the study population no cases of death or septicemia developed after start of initial oral treatment. A home-treatment regime for pyelonephritis in children 6months is safe; however, during treatment, clinical re-evaluation is required as in 20% of cases a change in treatment was necessary. 6 months is safe; however, during treatment, clinical re-ev